Baby formula with HMO and DHA/ARA may sharpen infant cognition, study finds
NCT ID NCT06146387
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial enrolled 240 healthy newborns to see if a formula containing HMO, DHA, and ARA improves cognitive scores at 12 months compared to a standard formula or breastfeeding. Babies were fed the assigned formula or breast milk for up to a year, and their thinking skills were measured using the Bayley-III test. The study aims to find out whether adding these nutrients to formula can support early brain development.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
infant formula with human milk oligosaccharides (HMO), DHA, and ARA
What this could lead to
If the formula shows better cognitive scores, it could support using specific nutrients in infant formula to aid early brain development.
What could go wrong
This is a single completed study with 240 infants, so results may not apply broadly. Cognitive tests at 12 months may not predict long-term intelligence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE CHANGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jinhua Nanyuan Community Health Center (site 1919)
Jinhua, Zhejiang, China
-
Li Pu Community Hospital
Jinhua, Zhejiang, China
-
Qiu Bin Community Hospital
Jinhua, Zhejiang, China